BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 182 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,185,342 | +301.2% | 1,448,060 | +161.7% | 0.00% | +300.0% |
| Q2 2023 | $9,518,702 | -37.2% | 553,413 | -39.5% | 0.00% | -50.0% |
| Q1 2023 | $15,167,234 | +88.5% | 914,791 | -13.4% | 0.00% | +100.0% |
| Q4 2022 | $8,045,477 | -20.9% | 1,055,837 | +3.1% | 0.00% | 0.0% |
| Q3 2022 | $10,176,000 | -16.0% | 1,023,814 | -23.3% | 0.00% | -50.0% |
| Q2 2022 | $12,118,000 | +3.2% | 1,334,460 | +15.3% | 0.00% | 0.0% |
| Q1 2022 | $11,743,000 | +78.5% | 1,156,938 | +193.3% | 0.00% | +100.0% |
| Q4 2021 | $6,579,000 | -36.1% | 394,487 | +79.7% | 0.00% | 0.0% |
| Q3 2021 | $10,288,000 | -56.4% | 219,509 | -43.3% | 0.00% | -66.7% |
| Q2 2021 | $23,616,000 | -13.6% | 387,418 | -12.6% | 0.00% | -25.0% |
| Q1 2021 | $27,320,000 | +417.9% | 443,502 | +497.8% | 0.00% | +300.0% |
| Q4 2020 | $5,275,000 | +493.4% | 74,185 | +213.1% | 0.00% | – |
| Q3 2020 | $889,000 | -54.2% | 23,691 | -60.2% | 0.00% | – |
| Q2 2020 | $1,941,000 | +198.6% | 59,517 | +165.5% | 0.00% | – |
| Q1 2020 | $650,000 | -51.6% | 22,415 | -41.4% | 0.00% | – |
| Q4 2019 | $1,342,000 | +625.4% | 38,270 | +345.6% | 0.00% | – |
| Q3 2019 | $185,000 | -76.9% | 8,588 | -71.1% | 0.00% | – |
| Q2 2019 | $801,000 | – | 29,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $100,609,513 | 48.41% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $514,990,899 | 15.50% |
| M28 Capital Management LP | 304,700 | $5,051,926 | 5.71% |
| Cormorant Asset Management, LP | 4,557,414 | $75,562 | 4.98% |
| Octagon Capital Advisors LP | 1,338,160 | $22,186,693 | 3.19% |
| Ikarian Capital, LLC | 594,686 | $9,859,894 | 2.24% |
| Affinity Asset Advisors, LLC | 389,800 | $6,462,884 | 2.13% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $441,376,031 | 2.07% |
| Ikarian Capital, LLC | 549,600 | $9,112,368 | 2.07% |
| Affinity Asset Advisors, LLC | 320,000 | $5,305,600 | 1.75% |